Ozagrel hydrochloride

Overview

Ozagrel hydrochloride (OKY-046 hydrochloride) is a high selective and orally active thromboxane A 2 (TXA 2 ) synthase inhibitor with an IC 50 of 11 nM. Ozagrel hydrochloride exerts anti-platelet aggregation, vasodilation and anti-inflammatory effects by inhibiting the production of TXA 2 and increasing the production of prostacyclin (PGI2) . Ozagrel hydrochloride can be used for the study of ischemic stroke, asthma and thromboembolic diseases.

Application

Products | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Prostaglandin Receptor

Product Information

• Catalog No.: HY-B0428B
• CAS No.: 78712-43-3
• Molecular Formula: C13H13ClN2O2
• Molecular Weight: 264.71
• Purity: 99.86%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.08 mg/mL (7.86 mM); Clear solution
• Availability: In-stock

Source

Original product source